Navigation Links
Verenium Announces First Commercial Cellulosic Ethanol Project
Date:1/15/2009

- Large-scale cellulosic ethanol facility in Florida to serve as model for future plants -

- "Farm to Fuel" grant provides State support to project -

CAMBRIDGE, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced plans to build its first commercial-scale cellulosic ethanol facility in Highlands County, Florida. The Company has entered into long-term agreements with Lykes Bros. Inc., a multi-generation Florida agri-business to provide the agricultural biomass for conversion to fuel. Verenium also announced that the Highlands Ethanol project has been awarded a $7 million grant as part of Florida's "Farm to Fuel" initiative. These announcements will be discussed today at a press briefing at the Florida Department of Agriculture and Consumer Services in Tallahassee, Florida.

Verenium's planned commercial facility will be the first in the State of Florida to use next-generation cellulosic ethanol technology to convert renewable grasses to fuel, rather than processing food crops. The plant will be constructed on fallow land, and is expected to produce up to 36 million gallons of cellulosic ethanol per year and provide the region with about 140 full-time jobs, once commercial operations begin. Verenium anticipates breaking ground on this facility in the second half of this year, and expects to start producing fuel in 2011. Additional jobs will be created during the 18-to-24 months of construction on the plant, which is estimated to cost between $250 and $300 million to build. Verenium recently received a special use permit from Highlands County for this facility, located in South Central Florida, and is in the process of finalizing other necessary permit applications.


'/>"/>
SOURCE Verenium Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
2. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
3. Verenium Corporation to Announce Third Quarter 2008 Financial Results
4. Verenium Corporation to Present at the William Blair & Company 2008 Small-Cap Growth Stock Conference
5. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
6. Verenium Appoints John F. Dee to Board of Directors
7. Verenium Reports Financial Results for the First Quarter 2008
8. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
9. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
10. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
11. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), a ... autologous cell therapies, announced today that RepliCel,s CEO, David ... in Minneapolis, Minnesota on August 5 ... highlight RepliCel,s 18-month milestones including CE Mark for its RCI-02 ... clinical data from both RCT-01 (tendon) and RCS-01 (skin) clinical ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... market analysis and premium industry insights on the global resorcinol industry. The report ... collective study of vivid market scenarios and analysis of primary and secondary inputs ...
(Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Vieillard as Sales & Marketing Director. , With more than 25 years ... responsible for reinforcing Tronics’ business development activities worldwide. He brings to the company ...
Breaking Biology Technology:RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... Joseph F. Finn, Jr., C.P.A. ("Finn"), announced ... been assigned to him for the benefit of Prospect,s ... designed to inhibit the activity of galectin-3, a protein ... human cancers and whose over-expression is associated with poor ...
... Sponsoring BrandsCINCINNATI, May 12 Healthy Advice ... office-based patient-education programs, announces another record performance in ... company continued to experience double-digit growth, posting 21% ... programs (a digital screen waiting room program and ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today ... present a company update at the Deutsche Bank 34th Annual ... at 1:55 p.m. ET. Interested parties may access a ... section of the BioMarin website, www.BMRN.com . ...
Cached Biology Technology:Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors 2Healthy Advice Networks Achieves Strong Growth Despite Challenging Economy 2BioMarin to Present at the Deutsche Bank Health Care Conference 2
(Date:7/31/2015)... 31 de julio de 2015 BGI llevará a ... ) del 22 al 25 de octubre de 2015, ... La conferencia celebra su décimo aniversario este año. Desde ... una de las reuniones anuales más influyentes del mundo ... de las conferencias científicas más dinámicas, entusiastas y amenas. ...
(Date:7/31/2015)... Die 10. internationale Konferenz zu Genomik ... und findet vom 22. bis 25. Oktober 2015 ... Die Konferenz feiert in diesem ... ist die ICG weltweit zu einem der einflussreichsten ... eines der dynamischsten, enthusiastischsten und angenehmsten wissenschaftlichen Zusammentreffen. ...
(Date:7/27/2015)... Calif. , July 27, 2015  Synaptics ... of human interface solutions, today announced that Huawei ... touchscreen solution for its stylish smartwatch. Huawei ... its proven reliability, low power and highly responsive ... wet finger. Huawei designers also required a classic ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3
... Researchers at the University of Iowa have created a ... putting DNA into a nano-sized particle that delivers bone-producing ... on a collagen platform seeded with particles containing the ... bio patch successfully regrew bone fully enough to cover ...
... drug-resistant breast cancer cells, according to a study published ... are just as small, or even smaller, than many ... of healthy and sick cells, which make them interesting ... In the present study, researchers from Karolinska Institutet ...
... for Brain Science announced today that it contracted ... and manufacture a state-of-the-art sensor array for recording ... for Brain Science in partnership with the Howard ... the Wellcome Trust and University College London (UCL), ...
Cached Biology News:A bio patch that can regrow bone 2A bio patch that can regrow bone 3Nanoparticles can overcome drug resistance in breast cancer cells 2Allen Institute for Brain Science partners with imec for development of next-generation tools 2
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
Mouse monoclonal antibody to Lats2....
Goat polyclonal to Lipocalin 2...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
Biology Products: